Results 161 to 170 of about 1,999,370 (297)
Molecular Oncology, EarlyView.High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
, 1925 A photo of Eugene McDermott, likely taken around the time he was a graduate student at Columbia University. He was a founder of GSI, and in the early years developed innovative designs for instruments that improved the business of ...
Texas Instruments Incorporated
core
Molecular Oncology, EarlyView.In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico +5 more
wiley +1 more source
[Texas Instruments Press Releases, April-May 1966]
, 1966 1. Release dated April 1, 1966 is in regard to a brochure (PEP-2) published by Metals & Controls, Inc. on innovations in contact materials and value analysis on contact applications. 2.
Texas Instruments Incorporated
core
Molecular Oncology, EarlyView.Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso +5 more
wiley +1 more source
[Texas Instruments Press Releases, October-December 1967]
, 1967 1. Press release dated October 2, 1967 is in regard to an address to the Boston Security Analysts Society by T.I. President and COO Mark Shepherd, Jr. on TI's past and current operations and future plans. Portions of Mr. Shepherd's remarks are reproduced.
Texas Instruments Incorporated
core
Molecular Oncology, EarlyView.The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim +17 more
wiley +1 more source
[Texas Instruments Press Releases, March 1970]
, 1970 1. Press release dated March 2, 1970 is in regard to TI's annual sales and earnings report for 1969. It includes a consolidated financial summary. 2. Press release dated March 2, 1970 announces the appointment of Richard W. Renzetti as President of Texas
Texas Instruments Incorporated
core
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
Conservative Custom Wire and Loop-Assisted Retrieval of a Long Separated Instrument Extending Beyond the Apex: A Case Report. [PDF]
CureusThomas M, G P, Ashok A, P AT.
europepmc +1 more source